-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$45.00151.82% Upside
Fulgent Genetics, Inc. Frequently Asked Questions
-
What analysts cover Fulgent Genetics, Inc.?
Fulgent Genetics, Inc. has been rated by research analysts at Piper Sandler, Raymond James, Credit Suisse in the past 90 days.